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A condensation reaction between 1-cyclobutyl-3,4-dihydroisoquinoline and thioglycolic acid has been carried out using 
DCC yields 10b-cyclobutyl-5,6-dihydro-2H-thiazolo [2, 3-a] isoquinolin-3(10bH)-one [CBIQTGA]. The synthesized 
compound is characterised by using spectroscopic techniques. The interaction of CBIQTGA with bovine serum albumin has 
been studied using UV spectroscopy, spectrofluorimetry and circular dichroism techniques. 
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Bovine serum albumin (BSA) is the most abundant 
and carrier protein which lies in blood plasma1. BSA 
consists of an amino acid chain of 537 residues. BSA 
gets divided into nine loops due to disulfide bonds 
into three structurally homologous domains. Intrinsic 
fluorescence is produced by tryptophan 134 which is 
located on the protein surface and tryptophan 212 
lies in a hydrophobic binding pocket of protein2-4. 
Hence quenching of fluorescence is made useful in 
determining the binding affinities. Heterocyclic 
compounds are well known for their versatile 
biological activites5. Nitrogen and sulphur containing 
heterocycle are profoundly used as antimalarial6 and 
antibacterial7 agents, respectively.  
Thiazolidinone8 is a five member heterocycle 
found in various drugs and exhibits several biological 
activites. Thiazolidinones are known to exhibit anti 
HIV9, anticancer10, antimalarial11, antitubercular12 
activites. Besides these they are also reported for 
their anticonvulsant13, antihypnotic14, antifungal15, 
antibacterial16 and anti-inflammatory17 activites. Some 
of thiazolidinones are known to possess insecticidal 
activity18. Recently thiazolidinone derivatives were 
reported for their antiproliferative19 activity. Moreover 
thiazolidinone-peptide hybrids were reported for 
their antidengue activity20. Thiazolidinone is the 
main functionality in known diabetic drugs including 
Rosiglitazone and Pioglitazone21. Rosiglitazone was 
investigated for their interaction with BSA22.  
Further the interaction of various thiazolo derivatives 
with BSA is also reported.23-27 The study of 
interaction of proteins with small molecules is 
important in the field of pharmacokinetics and 
pharmacodynamics28. BSA has structural analogy to 
human serum albumin29. 
The present study deals with the synthesis of new 
thiazolo derivative with its characterization by using 
different spectroscopic methods30. The synthesized 
derivative 10b-cyclobutyl-5,6-dihydro-2H-thiazolo [2, 
3-a] isoquinolin-3(10bH)-one [CBIQTGA] was
further studied for its binding interaction with BSA
using fluorescence spectroscopy, circular dichroism
(CD) spectroscopy.31
Materials and Methods 
Materials 
All required chemicals and BSA was purchased 
from Sigma-Aldrich India and used without further 
purification31. BSA stock solution was prepared by 
dissolving BSA in Tris-HCl buffer with pH= 7.2. In 
all the experiments, double distilled water was used 
for dilution. In 5% ethanol, 10b-cyclobutyl-5,6-
dihydro-2H-thiazolo[2,3-a] isoquinolin-3 (10bH) -one 
(CBIQTGA) stock solution (2.0×10-3 mol L-1) was 
prepared. All required solvents were of analytical 
grade and purchased from Sigma Aldrich, India. 




Synthesis of CBIQTGA 
A mixture of 1-cyclobutyl-3,4-dihydroisoquinoline 
(0.1 mol), thioglycolic acid (0.3 mol) were stirred in 
tetrahydrofuran at 0-5 °C for 15 min and then  
N,N-dicyclohexylcarbodiimide (0.4 mol) was added30. 
The reaction mixture was stirred for additional 50 min  
at room temperature. The dicyclohexylurea was 
removed by filtration and filtrate was concentrated to 
dryness. The residue was taken in ethyl acetate and it 
was washed with 10% aq. citric acid, water and  
10% aq. sodium hydrogen carbonate. Ethyl acetate 
extract was dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. The residue 
obtained was purified by column chromatography 
over silica gel (petroleum ether: chloroform 70:30) to 
obtain white solid. The reaction mechanism is shown 
in Scheme 1. The characterization spectra are given in 
Supplementary Data, Figs. S1-S4. 
Characterisation: Yield: 71%; melting point: 91 °C; 
IR (cm-1): 2971.41, 1667.28, 1411.92, 1330.27, 
1293.09, 751.94; 1H NMR (CDCl3): 7.04-7.25 (m, 4H 
aromatic), 1.72-1.85 (m, 2H, aliphatic), 1.91-2.02 (m, 
4H, aliphatic), 2.27-2.33 (m, 1H, aliphatic), 2.80-2.82 
(d, 1H, aliphatic  J=6 Hz), 3.00-3.12 (m, 1H, aliphatic), 
3.23-3.25 (d, 1H, aliphatic J=6 Hz), 3.56-3.61 (dd, 1H, 
aliphatic J=15 Hz), 3.75-3.80 (dd, 1H, aliphatic  
J=15 Hz), 4.39-4.46 (m, 1H, aliphatic); 13C NMR 
(CDCl3): 16.75, 23.90, 25.42, 27.97, 34.26, 37.42, 
46.44, 74.05, 125.66, 126.51, 127.48, 129.27, 131.42, 
139.71, 169.24; Mass spectra: M+ at m/z: 260.57. 
 
Preparation of BSA and CBIQTGA solution 
BSA solution (10 µM) was prepared based on  
a molecular weight of 66,000 Dalton in 0.1 M 
phosphate buffer31. Initially a stock solution (50 µM) 
of CBIQTGA was prepared and different concentrations 
(10, 20, 30, 40 and 50 µM) were prepared by serial 
dilution of the stock solution. 
 
Characterisation techinques 
Shimadzu RF-5301 PC spectrofluorophotometer 
was used to record the fluorescence. At 280 nm the 
excitation wavelength was set and emission was 
recorded in the range of 300-450 nm. Slit widths were 
kept at 5 nm each throughout the experiment.  
At 293, 298, and 310 K temperatures with different 
concentrations of CBIQTGA solution in a 1 cm  
quartz cell, the fluorescence emission of BSA was 
recorded. An incubation time of 30 min was set  
for all fluorescence measurements for different 
temperatures31-32. Shimadzu UV-2401 PC spectro-
photometer was used to record UV-visible spectra in 
the absence and presence of CBIQTGA at 298 K in 
the range of 250-310 nm. The quartz cuvette with  
1 cm path length was used. The absorbance Tris-HCl 
buffer solution was recorded and subtracted. Jasco,  
J-815, CD spectrometer was used to record the circular 
dichroism measurements. CD spectrum measurements 
for BSA were recorded in the far UV region with scan 
speed of 10 nm/min, in presence and absence of 
CBIQTGA. The band width was fixed at 5 nm31-33. 
 
Results and Discussion 
 
UV-visible spectra of BSA-CBIQTGA complex 
UV-visible spectra of BSA in absence and presence 
of CBIQTGA show absorption peak at 280 nm, which 
increases with the increase in concentration of 
CBIQTGA as shown in Fig. 1. The shifting of 
absorption position to lower wavelength region may 
be due to formation of ground state complex BSA-
CBIQTGA31-32. 
 
Fluorescence quenching of BSA in presence of CBIQTGA 
The fluorescence of BSA is due to tryptophan (Trp) 
moiety which is very sensitive. The fluorescence 
spectra (Fig. 2a) were recorded for the free BSA and 
mixed with different concentrations of CBIQTGA to 
study the interaction between them. The spectra 
indicate that the BSA has a strong emission band 
observed between 345-380 nm when excited at  
280 nm31-32. The intensity of this fluorescence band 
gradually decreases with increase in concentration of 
quencher i.e., CBIQTGA. This gradual decrease in the 
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These bands are characteristics of α helical structure of 
BSA39-40. The band intensity of BSA decreases with the 
addition of CBIQTGA. CD spectra of BSA reveal that 




A new derivative CBIQTGA was synthesized by 
simple method with good yield. UV study reveals the 
formation of CBIQTGA–BSA complex. Fluorescence 
spectra conclude the static quenching mechanism for 
binding between CBIQTGA and BSA. Negative  
value of free energy indicates that CBIQTGA-BSA 
complex formation is spontaneous process and 
negative value of entropy indicates hydrophilic 
interaction between BSA and CBIQTGA. Circular 
dichroism spectra show the binding between 
CBIQTGA and BSA alters the conformation of BSA. 
 
Supplementary Data 
Supplementary data associated with this  
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